Dihydronaphthalenone chalconoid derivatives as potential cathepsin B inhibitors; design, synthesis, cytotoxicity evaluation and docking analysis
DOI:
https://doi.org/10.1590/s2175-979020200004181074Keywords:
Aldol reaction; Benzylidene-dihydronaphthalenone; Cancer; Chalcone; Cysteine proteases; Microwave assisted synthesisAbstract
Cathepsin B, an abundant expressed cysteine peptidase, plays a key role in cancer cell proliferation, tumor metastasis, apoptosis, angiogenesis, invasion and migration. Therefore, development of cathepsin B inhibitors to treat cancer is of great significance. In this study, dihydronaphthalenone chalconoid derivatives containing different benzyliden moieties were synthesized via an efficient route in microwave condition that resulted in the desired compounds in high yields compared to acid- or base-catalyzed refluxing conditions. Cytotoxicity of the compounds was evaluated against K562, HT-29 and MCF-7 human cancer cell lines by MTT assay. P1, P3 and P9 (containing 4-OCH3, 3-NO2 and 4-CN moieties on phenyl ring, respectively) exhibited good cytotoxic activity with an IC50 range of 7.1-28.9 μM. Molecular docking analysis was carried out to investigate the possible interactions and binding modes of all compounds with cathepsin B. The most promising compounds, P1, P3 and P9 were well accommodated within the active site and had the least estimated free binding energies. It was concluded from both MTT assay and docking studies that some dihydronaphthalenone chalconoid derivatives could be suggested as effective cytotoxic agents and potential cathepsin B inhibitors.
Downloads
References
Aggarwal N, Sloane B F. Cathepsin B: multiple roles in cancer. Proteomics Clin Appl. 2014;8(5-6):427-437.
Bavadi M, Niknam K, Shahraki O. Novel pyrrole derivatives bearing sulfonamide groups: Synthesis in vitro cytotoxicity evaluation, molecular docking and DFT study. J Mol Struct. 2017;1146:242-253.
Cao Z, Yang J, Xu R, Song Q, Zhang X, Liu H, et al. Design, synthesis and evaluation of 4'-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment. Bioorg Med Chem. 2018;26(5):1102-1115.
Dimmock J R, Kandepu N M, Nazarali A J, Kowalchuk T P, Motaganahalli N, Quail J W, et al. Conformational and quantitative structure- activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones. J Med Chem. 1999;42(8):1358-1366.
Drutovic D, Chripkova M, Pilatova M, Kruzliak P, Perjesi P, Sarissky M, et al. Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells. Tumor Biology. 2014;35(10):9967-9975.
Ducki S, Rennison D, Woo M, Kendall A, Chabert J F D, McGown A T, et al. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity. Bioorg Med Chem. 2009;17(22):7698-7710.
Eatemadi A, Aiyelabegan H T, Negahdari B, Mazlomi M A, Daraee H, Daraee N, et al. Role of protease and protease inhibitors in cancer pathogenesis and treatment. Biomed Pharmacother. 2017;86:221-231.
Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol. 2001;153(5):999-1010.
Garg S, Raghav N. Inhibitory potential of some chalcones on cathepsins B, H and L. RSC Adv. 2015;5(89):72937-72949.
Hawash M M, Kahraman D C, Eren F, Atalay R C, Baytas S N. Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. Eur J Med Chem. 2017;129:12-26.
Huber I, Zupkó I, Kovács I J, Minorics R, Gulyás-Fekete G, Maász G, et al. Synthesis and antiproliferative activity of cyclic arylidene ketones: a direct comparison of monobenzylidene and dibenzylidene derivatives. Monatsh Chem Chem Mon. 2015;146(6):973-981.
Joyce J A, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai F-Y, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer cell. 2004;5(5):443-453.
Katsori A-M, Hadjipavlou-Litina D. Chalcones in cancer: understanding their role in terms of QSAR. Curr Med Chem. 2009;16(9):1062-1081.
Kim S-H, Lee E, Baek K H, Kwon H B, Woo H, Lee E-S, et al. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents. Bioorg Med Chem Lett. 2013;23(11):3320-3324.
Kocyigit U M, Budak Y, Gurdere M B, Erturk F, Yencilek B, Taslimi P, et al. Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles. Arch Physiol Biochem. 2018;124(1):61-68.
Kramer L, Turk D, Turk B. The future of cysteine cathepsins in disease management. Trends Pharmacol Sci. 2017;38(10):
Lawrence N J, Rennison D, McGown A T, Hadfield J A. The total synthesis of an aurone isolated from Uvaria hamiltonii: aurones and flavones as anticancer agents. Bioorg Med Chem Lett. 2003;13(21):3759-3763.
Lim I T, Meroueh S O, Lee M, Heeg M J, Mobashery S. Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis. J J Am Chem Soc. 2004;126(33):10271-10277.
Majumdar I D, Devanabanda A, Fox B, Schwartzman J, Cong H, Porco J A, et al. Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro. Biochem Biophys Res Commun. 2011;416(3):397-402.
Mathers C D, Loncar D. Updated projections of global mortality and burden of disease, 2002-2030: data sources, methods and results. Geneva: World Health Organization. 2005.
Nakhjiri M, Safavi M, Alipour E, Emami S, Atash A F, Jafari-Zavareh M, et al. Asymmetrical 2, 6-bis (benzylidene) cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Eur J Med Chem. 2012;50:113-123.
Nalla A K, Gorantla B, Gondi C S, Lakka S S, Rao J S. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther. 2010;17(9):599.
Prakasham A, Saxena A, Luqman S, Chanda D, Kaur T, Gupta A, et al. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization. Bioorg Med Chem. 2012;20(9):3049-3057.
Raghav N, Garg S. SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H. Eur J Pharm Sci. 2014;60:55-63.
Raghav N, Kaur R. Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L. I Int J Biol Macromol. 2015;80:710-724.
Raghav N, Singh M. Design, synthesis and docking studies of bischalcones based quinazoline-2 (1H)-ones and quinazoline-2 (1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H. Eur J Pharm Sci. 2014a;54:28-39.
Raghav N, Singh M. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H. Bioorg Med Chem. 2014b;22(15):4233-4245.
Ramalho S D, Bernades A, Demetrius G, Noda-Perez C, Vieira P C, dos Santos C Y, et al. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation. Chem Biodivers. 2013;10(11):1999-2006.
Ranjbar S, Akbari A, Edraki N, Khoshneviszadeh M, Hemmatian H, Firuzi O, et al. 6-Methoxy-3, 4-dihydronaphthalenone Chalcone-like Derivatives as Potent Tyrosinase Inhibitors and Radical Scavengers. Lett Drug Des Discov. 2018a;15(11):1170-1179.
Ranjbar S, Edraki N, Khoshneviszadeh M, Foroumadi A, Miri R, Khoshneviszadeh M. Design, synthesis, cytotoxicity evaluation and docking studies of 1, 2, 4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors. Res Pharm Sci. 2018b;13(1):1.
Ranjbar S, Firuzi O, Edraki N, Shahraki O, Saso L, Khoshneviszadeh M, et al. Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis. MedChemComm. 2017;8(10):1919-1933.
Ravish I, Raghav N. SAR studies of differently functionalized 4'-phenylchalcone based compounds as inhibitors of cathepsins B, H and L. RSC Adv. 2015;5(62):50440-50453.
Reddy M V B, Hung H-Y, Kuo P-C, Huang G-J, Chan Y-Y, Huang S-C, et al. Synthesis and biological evaluation of chalcone, dihydrochalcone, and 1, 3-diarylpropane analogs as anti-inflammatory agents. Bioorg Med Chem Lett. 2017;27(7):1547-1550.
Soliman D H, Farrag A M, Omran O. Design, Synthesis and In-Silico Studies of Novel Chalcones as Anti-Prostate Cancer and Cathepsin B Inhibitors. J Appl Pharm Sci. Vol. 2017;7(07):010-020.
Sosic I, Mitrovic A,Curic H, Knez D, Zugelj H B, Stefane B, et al. Cathepsin B inhibitors: Further exploration of the nitroxoline core. Bioorg Med Chem Lett. 2018;28(7):1239-1247.
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
